The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1-Reference-Cited by-同舟云学术

The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1

Published:2017-12-05 Issue:12 Volume:12 Page:e0189060
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sundström Linda,Myhre Susanna,Sundqvist Monika,Ahnmark Andrea,McCoull William,Raubo Piotr,Groombridge Sam D.,Polla Magnus,Nyström Ann-Christin,Kristensson Lisbeth,Någård Mats,Winzell Maria Sörhede^ORCID

Funder

AstraZeneca.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Group IDFETFC. The metabolic syndrome—a new worldwide definition;KG Alberti;Lancet (London, England),2005

2. Obesity and free fatty acids;G Boden;Endocrinology and metabolism clinics of North America,2008

3. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation;E Le Poul;The Journal of biological chemistry,2003

4. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120;A Hirasawa;Nature medicine,2005

5. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84;J Wang;The Journal of biological chemistry,2006

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?;Biomedicine & Pharmacotherapy;2024-03

2. Cellular mechanisms of incretin hormone secretion;Journal of Molecular Endocrinology;2024-01-19

3. The Effects of Artificial Sweeteners on Intestinal Nutrient-Sensing Receptors: Dr. Jekyll or Mr. Hyde?;Life;2023-12-20

4. Endocrine, genetic, and microbiome nexus of obesity and potential role of postbiotics: a narrative review;Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity;2023-10-20

5. GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2023-08-05